Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Novo Nordisk ADR announced earnings per share of kr0.7976 on revenue of kr5.62B. Analysts polled by Investing.com anticipated EPS of kr0.8178 on revenue of kr5.73B.
Novo Nordisk ADR shares are down 5.03% from the beginning of the year and are trading at kr106.37 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR shares gained 6.47% in intra-day trade the report.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of kr5.57 on revenue of kr80.33B, compared to forecasts EPS of kr5.21 on revenue of kr79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of kr2.59 on revenue of kr24.02B, compared to forecast for EPS of kr2.54 on revenue of kr23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar